NCT07551427 A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis Status NOT_YET_RECRUITING Phase PHASE2
NCT07521046 Tolerability of Ropeginterferon Alfa-2b Add-on to Ongoing Ruxolitinib Therapy in Myelofibrosis (RopeRux in Myelofibrosis) Status NOT_YET_RECRUITING Phase PHASE1
NCT07498205 Comparing Momelotinib and Ruxolitinib in People With Untreated Myelofibrosis and Low Blood Cell Counts Status NOT_YET_RECRUITING Phase PHASE4
NCT07480824 To Evaluate the Pharmacokinetics and Safety of TQ05105 Tablet in Hepatic Impairment Subjects Status RECRUITING Phase PHASE1
NCT07447817 Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias Status NOT_YET_RECRUITING Phase PHASE2
NCT07424950 Bomedemstat (IMG-7289) in Combination With Momelotinib in Patients With Myelofibrosis Status NOT_YET_RECRUITING Phase PHASE2
NCT07362225 MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) Status RECRUITING Phase N/A
NCT07357441 A Study to Evaluate the Demographics and Treatment Patterns of Myelofibrosis Patients Treated With Ruxolitinib in Turkey Status COMPLETED Phase N/A
NCT07342712 Clinical Trail to Evaluate the Effect of Long-term Treatment With Gecacitinib on Myelofibrosis and Gene Mutation Levels Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07281781 Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow Status RECRUITING Phase PHASE1/PHASE2
NCT07250646 A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis Status NOT_YET_RECRUITING Phase PHASE1
NCT07020533 A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant Status RECRUITING Phase PHASE1
NCT06923670 Prevalence Of Germline Gene Mutations In Patients With Myeloproliferative Neoplasms With Family History Status NOT_YET_RECRUITING Phase NA
NCT06859424 A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation Status RECRUITING Phase PHASE2
NCT06781099 Feasibility Trial of Extracorporeal Iron Purification in Patients With Myelodysplastic Syndrome or Myelofibrosis Status RECRUITING Phase NA
NCT06773195 A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis Status RECRUITING Phase PHASE1/PHASE2